To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Actively working, either full-time or part-time
Previous confirmed diagnosis of PsA by a rheumatologist
Patients for whom the physician has initiated PsA treatment with an Anti-TNF in accordance with Turkish Ministry of Health regulations and reimbursement criteria
Able to provide authorization to use and disclose their health related information
You may not be if
Patients with a history of an allergic reaction or significant sensitivity to anti-TNF agents
Patients with possible follow-up problems during the planned study period or patients who may not be compliant to treatment as evaluated by the investigator/treating physician
Patients participating in any clinical trial of an experimental drug 30 days prior to the baseline visit
Clareo Health | To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
